The Chemours Company (NYSE:CC) Shares Sold by Moore Capital Management LP

Moore Capital Management LP decreased its holdings in The Chemours Company (NYSE:CC - Free Report) by 38.7% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 644,188 shares of the specialty chemicals company's stock after selling 406,485 shares during the quarter. Moore Capital Management LP owned about 0.43% of Chemours worth $10,887,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in the business. Barclays PLC raised its stake in Chemours by 28.4% in the 3rd quarter. Barclays PLC now owns 107,549 shares of the specialty chemicals company's stock worth $2,185,000 after acquiring an additional 23,766 shares during the last quarter. GAMMA Investing LLC raised its stake in Chemours by 99.7% in the 4th quarter. GAMMA Investing LLC now owns 1,532 shares of the specialty chemicals company's stock worth $26,000 after acquiring an additional 765 shares during the last quarter. Matrix Trust Co raised its stake in Chemours by 715.7% in the 4th quarter. Matrix Trust Co now owns 9,952 shares of the specialty chemicals company's stock worth $168,000 after acquiring an additional 8,732 shares during the last quarter. Inspire Investing LLC raised its stake in Chemours by 17.4% in the 4th quarter. Inspire Investing LLC now owns 23,799 shares of the specialty chemicals company's stock worth $402,000 after acquiring an additional 3,523 shares during the last quarter. Finally, KBC Group NV raised its stake in Chemours by 38.2% in the 4th quarter. KBC Group NV now owns 6,176 shares of the specialty chemicals company's stock worth $104,000 after acquiring an additional 1,708 shares during the last quarter. Institutional investors and hedge funds own 76.26% of the company's stock.

Wall Street Analyst Weigh In

CC has been the subject of a number of research analyst reports. Mizuho set a $15.00 target price on Chemours in a research note on Tuesday, April 15th. Royal Bank of Canada reduced their price objective on Chemours from $17.00 to $14.00 and set an "outperform" rating for the company in a research note on Thursday, May 8th. UBS Group reduced their price objective on Chemours from $18.00 to $17.00 and set a "buy" rating for the company in a research note on Wednesday, May 7th. StockNews.com lowered Chemours from a "hold" rating to a "sell" rating in a research note on Thursday, May 8th. Finally, Truist Financial reduced their price objective on Chemours from $27.00 to $22.00 and set a "buy" rating for the company in a research note on Monday, April 14th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and five have assigned a buy rating to the stock. According to MarketBeat, the company has a consensus rating of "Hold" and a consensus price target of $17.56.

Chemours Price Performance

CC stock traded up $0.12 during trading on Friday, hitting $11.16. The stock had a trading volume of 3,510,367 shares, compared to its average volume of 2,027,198. The company has a debt-to-equity ratio of 6.70, a current ratio of 1.68 and a quick ratio of 0.92. The Chemours Company has a twelve month low of $9.33 and a twelve month high of $29.17. The stock has a market capitalization of $1.67 billion, a P/E ratio of 19.58 and a beta of 1.76. The company's 50-day moving average price is $12.31 and its two-hundred day moving average price is $16.30.

Chemours (NYSE:CC - Get Free Report) last posted its quarterly earnings data on Tuesday, May 6th. The specialty chemicals company reported $0.13 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.19 by ($0.06). The firm had revenue of $1.37 billion during the quarter, compared to analyst estimates of $1.36 billion. Chemours had a return on equity of 26.54% and a net margin of 1.51%. The company's quarterly revenue was up .4% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.32 earnings per share. As a group, research analysts predict that The Chemours Company will post 2.03 EPS for the current fiscal year.

Chemours Announces Dividend

The company also recently declared a dividend, which will be paid on Monday, June 16th. Stockholders of record on Monday, May 19th will be given a dividend of $0.0875 per share. This represents a dividend yield of 3.17%. The ex-dividend date is Friday, May 16th. Chemours's payout ratio is presently 175.00%.

Chemours Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.